Skip to content

C-reactive protein assisted prescribing for respiratory tract infections to stimulate Antibiotic stewardship; a randomised controlled trial in general practice.

C-reactive protein assisted prescribing for respiratory tract infections to stimulate Antibiotic stewardship; a randomised controlled trial in general practice.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29094
Enrollment
200
Registered
2007-11-02
Start date
2007-11-05
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Lower respiratory tract infections (LRTI)

Interventions

PoC CRP assisted antibiotic prescribing including delayed prescribing compared to usual care.

Sponsors

University of Maastricht Care and Public Health Research Institute PO Box 616 6200 MD Maastricht The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The GPs will include adult patients (>=18 years) with acute LRTI or rhinosinusitis during normal consultation hours. The patient must meet the inclusion criteria listed below. Inclusion criteria: LRTI: First consultation of current episode of acute cough (duration <4 weeks) Regarded by the GP to be caused by an acute lower respiratory tract infection: 1. At least one out of following 4: Shortness of breath / wheezing / chest pain / auscultation abnormalities; 2. At least one of the following 5: Fever / perspiring / headache / myalgia / feeling generally unwell. Rhinosinusitis: First consultation of current episode of rhinosinusitis (duration <4 weeks) At time of consultation one of the following symptoms: 1. History of rhinorroe; 2. Blocked nose; AND one of the following symptoms/signs: 1. purulent rhinorroe; 2. unilateral facial pain; 3. headache; 4. teethpain; 5. pain when cheewing; 6. maxillary/frontal pain when bending over; 7. worsening of symptoms after initial improvement.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients who require immediate admission to hospital; 2. Patients who have no understanding of written and/or Dutch language; 3. Patients who previously participated in the study; 4. Patients who currently use antibiotic or have taken an antibiotic in the past 2 weeks; 5. Patients who have been hospitalized in the past 2 weeks; 6. Severely immuno-compromised patients.

Design outcomes

Primary

MeasureTime frame
Prescribing rates at index consultation (day 0), defined as immediate, delayed or no antibiotics.

Secondary

MeasureTime frame
Secondary study parameters/outcome of the study (if applicable): 1. Total antibiotic exposure over a period of 28 days, defined as the number of patients receiving immediate antibiotics or filling a delayed prescription for antibiotics within 28 days of index consultation (day 0); 2. Clinical recovery; 3. Patient satisfaction and enablement; 4. Reconsultation within 28 days; 5. Evaluation of GPs' estimation of CRP value based on usual diagnostic work-up (medical history and physical examination) compared to actual CRP test result; 6. CRP value on day 0 and day 7 in relation to perceived degree of illness (VAS, Visual Analogue Scale).

Contacts

Public ContactRogier Hopstaken

PO Box 616

rogier.hopstaken@hag.unimaas.nl+31 402548688

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)